Found 8 matching trials
A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome PHASE2 This is a Phase 2 study with an initial 24-week Treatment Period and an Ext...
Show More Location
University of Washington Medical Center
Learn More & Join Trial
Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients PHASE1 New treatment options are critical for treatment-experienced HIV infected p...
Show More Location
Alabama Therapeutics CRS
Learn More & Join Trial
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma PHASE1 The goals of this protocol are 1) to investigate the safety and tolerabilit...
Show More Learn More & Join Trial
Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome PHASE3 This study has a double-blind, Randomized Placebo-Controlled Period and an ...
Show More Location
University of California San Diego Health/Rady Children's Hospital
Learn More & Join Trial
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus PHASE1 The purpose of this study is to determine the safety and activity of AMD110...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers PHASE1 This study will evaluate the safety, tolerability and pharmacokinetics of X...
Show More Location
Covance CRU, Inc.
Learn More & Join Trial
Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma PHASE1 The purpose of the study is to test different doses of X4P-001 given alone ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men PHASE1 Most currently approved anti-HIV drugs work by stopping the replication of ...
Show More Location
Johns Hopkins Adult AIDS CRS
Learn More & Join Trial